Clinical experience with high success rate of antiretroviral therapy in elderly HIV-infected patients [9]

Age and Ageing

Volumn 33, Issue 5, 2004, Pages 520-521

  Sungkanuparph, Somnuek ^a   Manosuthi, Weerawat ^a   Kiertiburanakul, Sasisopin ^a   Vibhagool, Asda ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

AGED; ANEMIA; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FUNGAL MENINGITIS; GERIATRIC PATIENT; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RISK; LETTER; LYMPHOCYTE COUNT; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS;

AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 4544351600     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afh152     Document Type: Letter

References (5)

1. Pezzotti P, Phillips AN, Dorrucci M et al. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. Br Med J 1996; 313: 583-6.
2. Pallela FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60.
3. Manfredi R, Calza L, Cocchi D, Chiodo F. Antiretroviral treatment and advanced age: epidemiologic, laboratory, and clinical features in the elderly. J Acquir Immune Defic Syndr 2003; 33: 112-4.
4. Chiao EY, Ries KM, Sande MA. AIDS and the elderly. Clin Infect Dis 1999; 28: 740-5.
5. Skiest DJ, Keiser P. Human immunodeficiency virus infection in patients older than 50 years: a survey of primary care physicians' beliefs, practices, and knowledge. Arch Fam Med 1997; 6: 289-94.